Under the University and Small Business Patent Procedures Act of 1980 (35 U.S.C. §§ 200-212), commonly referred to as the Bayh-Dole Act, the federal government can exercise “march-in” authority in certain circumstances to...more
1/11/2024
/ Bayh-Dole Act ,
Biden Administration ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Hatch-Waxman ,
Healthcare ,
Inventions ,
March-in Rights ,
National Institute of Health (NIH) ,
NIST ,
Patent Ownership ,
Patents ,
Public Comment ,
Regulatory Agenda ,
Regulatory Reform ,
Request For Information